Loading organizations...
Lightchain AI offers a blockchain ecosystem integrating artificial intelligence for scalability and transparency. Its core features include a Proof of Intelligence (PoI) consensus, rewarding nodes for AI computations like model training. It also provides an Artificial Intelligence Virtual Machine (AIVM) for seamless, on-chain AI task execution, supporting advanced decentralized application development.
The project began with prototype development in November 2024, followed by a public testnet rollout in February 2025. This recent origin stems from the insight that embedding AI directly into blockchain operations overcomes traditional limitations. This approach fosters a more efficient, secure, and adaptive distributed ledger.
Lightchain AI targets developers for sophisticated decentralized applications, seeking enterprise integration in finance and healthcare for AI use cases. The company envisions a secure, equitable, and intelligent blockchain future, driven by open innovation, transparent AI frameworks, and community-led governance for continuous evolution.
Lightchain has 1 tracked investment across 1 company. The latest tracked deal is $105.0M Series C in Arch Oncology in May 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 23, 2021 | Arch Oncology | $105.0M Series C | JOE Biller, CFA, Eric Pham, JOY Ghosh | Adage Capital Management, Avego Healthcare Capital, Broadfin Holdings, FMB Research, Point72, John Mckearn, Roche |
